Who can participate?
Individuals who are 55-90, who have a diagnosis of Mild Cognitive Impairment (MCI or Alzheimer's Disease (AD). Who have a reliable study partner who has frequent contact and who can accompanying you to the study visits for the duration on the study and who are willing to participate in repeated imaging and biomarker collection.
What does the study include?
If you agree and are eligible to participate in the study, you will be asked to come in for:
- an initial screening visit and baseline visit
- an annual or biannual follow-up clinic visit
Screening Procedures include:
- Brain imaging such as MRI and PET/CT scans
- Memory Testing
- Physical and Neurological Exam
- Lumbar Puncture
- Blood Draw
Before enrolling into the study, the participant and study partner must read, understand, and sign a formal consent, which fully explains the study.
How understandable was the trial content above?
Hard to understand
Easy to understand
